Cell surface nucleolin antagonist causes endothelial cell apoptosis and normalization of tumor vasculature

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Angiogenesis

• Publication date

  2009-02-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10456-009-9137-5PMID 19225898
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vascular normalization in Rgs5-deficient tumours promotes immune destruction

  2008cited by this paper
• Suppression of Tumor Growth and Angiogenesis by a Specific Antagonist of the Cell-Surface Expressed Nucleolin

  2008cited by this paper
• Lessons from multidisciplinary translational trials on anti-angiogenic therapy of cancer

  2008cited by this paper
• Nucleolin stabilizes Bcl-X L messenger RNA in response to UVA irradiation.

  2008cited by this paper
• The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells.

  2008cited by this paper
• Bevacizumab-Induced Transient Remodeling of the Vasculature in Neuroblastoma Xenografts Results in Improved Delivery and Efficacy of Systemically Administered Chemotherapy

  2007cited by this paper
• Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization.

  2007cited by this paper
• Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin.

  2007cited by this paper
• Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA.

  2007cited by this paper
• Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer.

  2007cited by this paper
• The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin.

  2006cited by this paper
• Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.

  2006cited by this paper
• Antiangiogenic therapy for cancer: current and emerging concepts.

  2005cited by this paper
• Role of nucleolin in posttranscriptional control of MMP-9 expression.

  2005cited by this paper
• Endostatin's antiangiogenic signaling network.

  2004cited by this paper
• Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

  2004cited by this paper
• Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases.

  2004cited by this paper
• Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels

  2003cited by this paper
• Cell Surface-localized Nucleolin Is a Eukaryotic Receptor for the Adhesin Intimin-γ of Enterohemorrhagic Escherichia coliO157:H7*

  2002cited by this paper
• Specialization of tumour vasculature

  2002cited by this paper
• Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors.

  2002cited by this paper
• The Anti-HIV Cytokine Midkine Binds the Cell Surface-expressed Nucleolin as a Low Affinity Receptor*

  2002cited by this paper
• Identification of nucleolin as a new L-selectin ligand.

  2001cited by this paper
• An in vivo function for the transforming Myc protein: elicitation of the angiogenic phenotype.

  2000cited by this paper
• Genes expressed in human tumor endothelium.

  2000cited by this paper
• Molecular dissection of nucleolin's role in growth and cell proliferation: new insights

  1999cited by this paper
• Endostatin Induces Endothelial Cell Apoptosis*

  1999cited by this paper
• FGF-2 dependent angiogenesis is a latent phenotype in basic fibroblast growth factor transgenic mice.

  1999cited by this paper
• Structure and functions of nucleolin.

  1999cited by this paper
• Effect of laminin on the nuclear localization of nucleolin in rat intestinal epithelial IEC-6 cells.

  1998cited by this paper
• Patterns and Emerging Mechanisms Review of the Angiogenic Switch during Tumorigenesis

  1996cited by this paper
• Major nucleolar proteins shuttle between nucleus and cytoplasm.

  1989cited by this paper

• Unmodified RNA sequences form unusual stable G-quadruplexes with potential anti-RSV and anti-angiogenesis applications

  2025cites this paper
• Vascular environment-responsive DNA nanoswitch controls the positive feedback system for spatiotemporal coupling of angiogenesis and osteogenesis.

  2025cites this paper
• A CYCLIC PEPTIDE TARGETS GLIOBLASTOMA BY BINDING TO ABERRANTLY EXPOSED SNAP25

  2024cites this paper
• A Cyclic Peptide Targets Glioblastoma by Binding to Aberrantly Exposed SNAP25.

  2024cites this paper
• Tumor-Suppressive Cross-Linking of Anti-T. cruzi Antibodies in Acute Lymphoblastic Leukemia

  2024cites this paper
• Multi‐Catcher Polymers Regulate the Nucleolin Cluster on the Cell Surface for Cancer Therapy

  2023cites this paper
• Anti-nucleolin aptamer AS1411: an advancing therapeutic

  2023cites this paper
• Nucleolin-based targeting strategies in cancer treatment: Focus on cancer immunotherapy (Review)

  2023cites this paper
• Nucleolin promotes angiogenesis and endothelial metabolism along the oncofetal axis in the human brain vasculature

  2023cites this paper
• RNA-Binding Proteins in Bladder Cancer

  2023cites this paper
• Atomic layer deposition (ALD)-constructed TaS2 nanoflakes for cancer-related nucleolin detection

  2023cites this paper
• Fluorescent Polymer-AS1411-Aptamer Probe for dSTORM Super-Resolution Imaging of Endogenous Nucleolin.

  2022cites this paper
• Overexpression of Nucleolin and Associated Genes in Prostate Cancer

  2022cites this paper
• Cell surface nucleolin as active bait for nanomedicine in cancer therapy: a promising option

  2021cites this paper
• Probing Vasculature by In Vivo Phage Display for Target Organ-Specific Delivery in Regenerative Medicine

  2021cites this paper
• Cancer Stem Cells and Nucleolin as Drivers of Carcinogenesis

  2021cites this paper
• Targeted drug delivery vehicles mediated by nanocarriers and aptamers for posterior eye disease therapeutics: barriers, recent advances and potential opportunities

  2021cites this paper
• Nxhl Controls Angiogenesis by Targeting VE-PTP Through Interaction With Nucleolin

  2021cites this paper
• Vascular normalisation as the stepping stone into tumour microenvironment transformation

  2021cites this paper
• Carrier-free nanodrugs with efficient drug delivery and release for cancer therapy: From intrinsic physicochemical properties to external modification

  2021cites this paper
• Exploration of Oxygen-Induced Retinopathy Model to Discover New Therapeutic Drug Targets in Retinopathies

  2020cites this paper
• Electrochemiluminescence Biosensor for Nucleolin Imaging in Single Tumor Cell Combined with Synergetic Therapy of Tumor.

  2020cites this paper
• Inhibition of miR‐155 in MCF‐7 breast cancer cell line by gold nanoparticles functionalized with antagomir and AS1411 aptamer

  2020cites this paper
• Tumor Hypoxia: Impact on Radiation Therapy and Molecular Pathways

  2020cites this paper
• Nucleolin is expressed in human fetal brain development and reactivated in human glial brain tumors regulating angiogenesis and vascular metabolism

  2020cites this paper
• Whole Genome and Embryo Transcriptome Analysis of Vertebrate Identifies nxhl Controlling Angiogenesis by Targeting VE-PTP

  2020cites this paper
• Nucleolin-based targeting strategies for cancer therapy: from targeted drug delivery to cytotoxic ligands.

  2019cites this paper
• Retina SWATH-MS Proteomic Analysis of Oxygen-Induced Retinopathy Reveals Novel Potential Therapeutic Targets

  2018cites this paper
• Multifaceted Nucleolin Protein and Its Molecular Partners in Oncogenesis.

  2018cites this paper
• Meeting the needs of breast cancer: A nucleolin's perspective.

  2018cites this paper
• Anticancer activity and antibody-dependent cell-mediated cytotoxicity of novel anti-nucleolin antibodies

  2018cites this paper
• Targeted therapy of human glioblastoma via delivery of a toxin through a peptide directed to cell surface nucleolin

  2018cites this paper
• Nucleolin protects against doxorubicin‐induced cardiotoxicity via upregulating microRNA‐21

  2018cites this paper
• SWATH-MS Proteomic Analysis of Oxygen-Induced Retinopathy Reveals Novel Potential Therapeutic Targets.

  2018cites this paper
• Tumor-penetrating peptides

  2018cites this paper
• Targeting nucleolin for better survival in diffuse large B-cell lymphoma

  2018cites this paper
• Strategies of Engineering Nanoparticles for Treating Neurodegenerative Disorders.

  2017cites this paper
• Precise glioblastoma targeting by AS1411 aptamer-functionalized poly (l-γ-glutamylglutamine)-paclitaxel nanoconjugates.

  2017cites this paper
• New perspectives of physiological and pathological functions of nucleolin (NCL)

  2017cites this paper
• Chemical Design and Synthesis of Functionalized Probes for Imaging and Treating Tumor Hypoxia.

  2017cites this paper
• The cancer stem cell phenotype as a determinant factor of the heterotypic nature of breast tumors.

  2017cites this paper
• In vitro characterization and in vivo ultrasound molecular imaging of nucleolin-targeted microbubbles.

  2017cites this paper
• Blind SELEX Approach Identifies RNA Aptamers That Regulate EMT and Inhibit Metastasis

  2017cites this paper
• Osteoprotegerin rich tumor microenvironment: implications in breast cancer

  2016cites this paper
• Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor Vasculature.

  2016cites this paper
• A novel fully human anti-NCL immunoRNase for triple-negative breast cancer therapy

  2016cites this paper
• Regulation of PTN expression by hypoxia and hypoxia-induced factors and possible functional significance

  2016cites this paper
• Novel approaches for breast cancer therapy : exploiting fully human immunoRNases targeting ErbB 2-positive and triple-negative breast cancers Candidate

  2016cites this paper
• A role of nucleolin in human hematopoietic progenitor cells

  2015cites this paper
• Plasma and cellular pharmacokinetic considerations for the development and optimization of antitumor block copolymer micelles

  2015cites this paper
• Targeted intracellular delivery of synergistic drug combinations: tackling drug resistance in human breast cancer

  2015cites this paper
• Tissue and cellular characterisation of nucleolin in a murine model of corneal angiogenesis

  2015cites this paper
• Bionanotechnology and the Future of Glioma

  2015cites this paper
• Stressing on the nucleolus in cardiovascular disease.

  2014cites this paper
• Nucleolin Down-Regulation Is Involved in ADP-Induced Cell Cycle Arrest in S Phase and Cell Apoptosis in Vascular Endothelial Cells

  2014cites this paper
• Hypoxia, Metastasis, and Antiangiogenic Therapies

  2014cites this paper
• Cell surface nucleolin as a target for anti-cancer therapies.

  2014cites this paper
• Tumor homing peptides for drug delivery and imaging.

  2013cites this paper
• Prognostic Significance of the Combined Score of Endothelial Expression of Nucleolin and CD31 in Surgically Resected Non-Small Cell Lung Cancer

  2013cites this paper
• apoptosis in vivo via a surface nucleolin-Fas complex Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated

  2013cites this paper
• Apoptosis in glioma-bearing rats after neural stem cell transplantation

  2013cites this paper
• Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex.

  2013cites this paper
• The Role of Nucleolin in B-cell Lymphomas and Fas-Mediated Apoptotic Signaling

  2013cites this paper
• Interplay between αvβ3 Integrin and Nucleolin Regulates Human Endothelial and Glioma Cell Migration*

  2012cites this paper
• Preview : Published ahead of advance online publication

  2012cites this paper
• Nanotechnology—novel therapeutics for CNS disorders

  2012cites this paper
• The pseudopeptide HB-19 binds to cell surface nucleolin and inhibits angiogenesis

  2012cites this paper
• The nuclear translocation of endostatin is mediated by its receptor nucleolin in endothelial cells

  2012cites this paper
• Pleiotrophin expression and role in physiological angiogenesis in vivo: potential involvement of nucleolin

  2012cites this paper
• Heat Shock Cognate 70 Regulates the Translocation and Angiogenic Function of Nucleolin

  2012cites this paper
• RNA-binding protein nucleolin in disease

  2012cites this paper
• Refined Mapping of a Quantitative Trait Locus on Chromosome 1 Responsible for Mouse Embryonic Death

  2012cites this paper
• Antibodies Against Nucleolin in Recipients of Organ Transplants

  2011cites this paper
• Identification and characterization of adenovirus early region 1B-associated protein 5 as a surface marker on undifferentiated human embryonic stem cells.

  2011cites this paper
• Microvascular Modifications in Diabetic Retinopathy

  2011cites this paper
• Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type

  2011cites this paper
• DDEDEDDDDD EDDEDDDDED DEEEEEEEEE EPVKEAPGKR KKEMAKQKAA PEAKKQKVEG . 301 TEPTTAFNLF VGNLNFNKSA PELKTGISDV FAKNDLAVVD VRIGMTRKFG YVDFESAEDL . 361 EKALELTGLK VFGNEIKLEK PKGKDSKKER DARTLLAKNL PYKVTQDELK EVFEDAAEIR . 421 LVSKDGKSKG IAYIEFKTEA DAEKTFEEKQ GTEIDGRSIS LYYTGEKGQN QDYRGGKNST

  2011cites this paper
• Identification of a putative Crimean-Congo hemorrhagic fever virus entry factor.

  2011cites this paper
• Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery.

  2011cites this paper
• JCB: Review

  2011cites this paper
• Evaluation of the highly sensitized transplant recipient

  2011cites this paper
• Interactome study suggests multiple cellular functions of hepatoma-derived growth factor (HDGF).

  2011cites this paper
• A simple approach to cancer therapy afforded by multivalent pseudopeptides that target cell-surface nucleoproteins.

  2011cites this paper
• Nucleolin/C23 mediates the antiapoptotic effect of heat shock protein 70 during oxidative stress

  2010cites this paper
• Secretome-based identification and characterization of potential biomarkers in thyroid cancer.

  2010cites this paper
• Liposomes targeting tumour stromal cells

  2010cites this paper
• Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice

  2010influential citation
• Surface Expressed Nucleolin Is Constantly Induced in Tumor Cells to Mediate Calcium-Dependent Ligand Internalization

  2010cites this paper
• ADAMTS-2 functions as anti-angiogenic and anti-tumoral molecule independently of its catalytic activity

  2010cites this paper
• Targeting of drugs and nanoparticles to tumors

  2010cites this paper
• Homing peptides as targeted delivery vehicles.

  2010cites this paper
• AS-1411, a guanosine-rich oligonucleotide aptamer targeting nucleolin for the potential treatment of cancer, including acute myeloid leukemia.

  2010cites this paper
• Plasma Membrane Nucleolin Is a Receptor for the Anticancer Aptamer AS1411 in MV4-11 Leukemia Cells

  2009cites this paper
• Adenylyl Cyclase–A-kinase Anchoring Protein Complexes: The Next Dimension in cAMP Signaling

  2009cites this paper
• Identification and Characterization of Adenovirus Early Region 1B-Associated Protein 5 as a Surface Marker on Undifferentiated Human Embryonic Stem Cells

  year unknowncites this paper
• MIT Open Access Articles Targeting of drugs and nanoparticles to tumors

  year unknowncites this paper